Transoral laser microsurgery for T3 laryngeal tumors: Prognostic factors

Head and Neck

Volumn 32, Issue 7, 2010, Pages 929-938

  Vilaseca, Isabel ^a,b,c   Bernal Sprekelsen, Manuel ^a   Blanch, José Luis ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Advanced laryngeal cancer; CO2 laser; Organ preservation; Transoral laser microsurgery

Indexed keywords

ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; FEMALE; HEAD AND NECK CANCER; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; LARYNX TUMOR; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MOUTH CAVITY; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL APPROACH; TREATMENT OUTCOME; VOCAL CORD;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LASER THERAPY; LASERS, GAS; MALE; MICROSURGERY; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954395537     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21288     Document Type: Article

References (39)

1. Steiner W. Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract. Adv Otorhinolaryngol 1988;39:135-144.
2. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116-121.
3. Steiner W, Ambrosch P. CO2 laser microsurgery for laryngeal cancer. Proceedings of the Second World Congress on laryngeal cancer. Sydney 1994. Smee R, Bridger GP (Eds). Elsevier Amsterdam-Lausanne-New York-Oxford-Shannon-Tokyo 1994, p 369-372.
4. Eckel HE, Thumfart W, Jungehülsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur Arch Otorhinolaryngol 2000;257:221-226.
5. Peretti G, Piazza C, Mensi MC, Magnoni L, Bolzoni A. Endoscopic treatment of cT2 glottic carcinoma: prognostic impact of different pT subcategories. Ann Otol Rhinol Laryngol 2005;114:579-586. (Pubitemid 41170047)
6. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer: follow-up of 141 patients. Arch Otolaryngol Head Neck Surg 1998;124:1245-1250. (Pubitemid 28522964)
7. Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann Otol Rhinol Laryngol 1999;108:819-827. (Pubitemid 29461192)
8. Pearson BW, Salassa JR. Transoral laser microresection for cancer of the larynx involving the anterior commissure. Laryngoscope 2003;113:1104-1112.
9. Vilaseca I, Blanch JL, Bernal-Sprekelsen M, Moragas M. CO2 laser surgery: a larynx preservation alternative for selected hypopharyngeal carcinomas. Head Neck 2004;26:953-959.
10. Hinni ML, Salassa JR, Grant DG, et al. Transoral laser microsurgery for advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007;133:1198-1204.
11. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg 2007;136:900-906.
12. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for untreated glottic carcinoma. Otolaryngol Head Neck Surg 2007;137:482-486.
13. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th ed. Springer, New York.
14. Steiner W, Ambrosch P (2000) Endoscopic laser surgery of the upper aerodigestive tract. Thieme Stuttgart, New York.
15. Blanch JL, Vilaseca I, Bernal-Sprekelsen M, et al. Prognostic significance of surgical margins in transoral CO2 laser microsurgery for T1-T4 pharyngo-laryngeal cancers. Eur Arch Otorhinolaryngol 2007;264:1045-1051.
16. VA Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-1690.
17. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
18. Forastiere AA, Maor M, Weber RS, et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynx-induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol 2006;24:5517.
19. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:1-13.
20. Suárez C, Rodrigo JP, Herranz J, Llorente JL, Martínez JA. Supraglottic laryngectomy with or without postoperative radiotherapy in supraglottic carcinomas. Ann Otol Rhinol Laryngol 1995;104:358-363.
21. Herranz J, Martínez-Vidal J, Martínez Morán A. Supraglottic laryngectomy. Still on-going. [Article in Spanish] Acta Otorrinolaringol Esp 2006;57:235-241.
22. Scola B, Fernández-Vega M, Martínez T, Fernández- Vega S, Ramirez C. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg 2001;124:195-198.
23. Nicolai P, Redaelli de Zinis LO, Tomenzoli D, et al. Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 1997;19:323-334. (Pubitemid 27273111)
24. Schwaab G, Kolb F, Pulieron M, et al. Subtotal laryngectomy with cricohyoidopexy as first treatment procedure for supraglottic carcinoma: Insitut Gustave-Roussy experience (146 cases, 1974-1997). Eur Arch Otorhinolaryngol 2001;258:246-249.
25. Laccourreye O, Brasnu D, Merite-Drancy A, et al. Cricohyoidopexy in selected infrahyoid epiglottic carcinomas presenting with pathological pre-epiglottic space invasian. Arch Otolaryngol Head Neck Surg 1993;119:881-886. (Pubitemid 23232297)
26. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol 1997;106:364-369. (Pubitemid 27212879)
27. Dufour X, Hans S, De Mones E, Brasnu D, Ménard M, Laccourreye O. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg 2004;130:1092-1099.
28. Bernal-Sprekelsen M, Vilaseca-González I, Blanch-Alejandro JL. Predictive values for aspiration after endoscopic laser resections of malignant tumors of the hypopharynx and larynx. Head Neck 2004;26:103-110.
29. Rodrigo JP, Suárez C, Silver CE, et al. Transoral laser surgery for supraglottic cancer. Head Neck 2008;30:658-666.
30. Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007;15:82-88.
31. Vilaseca-González I, Bernal-Sprekelsen M, Blanch-Alejandro JL, Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck 2003;25:382-388.
32. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol 1998;107:680-688. (Pubitemid 28371389)
33. Bernal-Sprekelsen M, Dazert S, Sudhoff H, Blanch JL, Vilaseca I. Complications of transoral laser surgery for malignant tumors of the larynx and hypopharynx. [Article in German] Laryngorhinootologie 2009;88:28-34.
34. Ellies M, Steiner W. Peri- and postoperative complications after laser surgery of tumors of the upper aerodigestive tract. Am J Otolaryngol 2007;28:168-172.
35. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804.
36. Jeremic B, Shibamoto T, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent lowdose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 2000;18:1458-1464.
37. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
38. Huguenin P, Beer KT, Allal A, et al. Concomitant cisplatin significantly improves locoregional control in head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004;22:4665-4673.
39. Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Robbins KT. Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck 2002;24:456-467.